Avalo Therapeutics

AVTXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$969.183 M

$18.32 -2.03%

Close of 7 Aug 2026

Revenue

$59.0K

#3628 by revenue

Earnings

-$78.3M

Loss-making

Shares outstanding

53,629,989

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#161Pacira BioSciencesPCRX$997.3M
#162ArdelyxARDX$988.1M
#163Avalo TherapeuticsAVTX$969.2M
#164Adlai NortyeANL$967.6M
#165Janux TherapeuticsJANX$966.6M

Where these numbers come from

Share counts and financials for Avalo Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.